These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31432447)

  • 21. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.
    Colak Y; Karabay CY; Tuncer I; Kocabay G; Kalayci A; Senates E; Ozturk O; Doganay HL; Enc FY; Ulasoglu C; Kiziltas S
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):613-8. PubMed ID: 22495402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Meta-Analysis of Different Types of Cardiac Adipose Tissue in HIV Patients.
    Song G; Qiao W; Sun L; Yu X
    Biomed Res Int; 2020; 2020():8234618. PubMed ID: 33376740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis.
    Xu Y; Cheng X; Hong K; Huang C; Wan L
    Coron Artery Dis; 2012 Jun; 23(4):227-33. PubMed ID: 22361934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk.
    Villasante Fricke AC; Iacobellis G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease.
    Eslam M; George J
    Hepatol Int; 2019 Nov; 13(6):662-664. PubMed ID: 31586267
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
    Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
    BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
    Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
    Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population.
    Meng X; Wang W; Zhang K; Qi Y; An S; Wang S; Zheng J; Kong J; Liu H; Wu J; Zhou Y; Gao C; Tang YD
    Ther Clin Risk Manag; 2018; 14():1499-1506. PubMed ID: 30197519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis.
    Mahfood Haddad T; Hamdeh S; Kanmanthareddy A; Alla VM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S209-S216. PubMed ID: 28017631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients.
    Guaraldi G; Scaglioni R; Zona S; Orlando G; Carli F; Ligabue G; Besutti G; Bagni P; Rossi R; Modena MG; Raggi P
    AIDS; 2011 Jun; 25(9):1199-205. PubMed ID: 21505301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.
    Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A
    Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Epicardial Adipose Tissue and High-Risk Plaque Characteristics: A Systematic Review and Meta-Analysis.
    Nerlekar N; Brown AJ; Muthalaly RG; Talman A; Hettige T; Cameron JD; Wong DTL
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
    Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
    Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis.
    Yong JN; Ng CH; Lee CW; Chan YY; Tang ASP; Teng M; Tan DJH; Lim WH; Quek J; Xiao J; Chin YH; Foo R; Chan M; Lin W; Noureddin M; Siddiqui MS; Muthiah MD; Sanyal A; Chew NWS
    Hepatol Int; 2022 Apr; 16(2):269-281. PubMed ID: 35320497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.
    Scorletti E; Afolabi PR; Miles EA; Smith DE; Almehmadi A; Alshathry A; Moyses HE; Clough GF; Wright M; Patel J; Bindels L; Delzenne NM; Calder PC; Byrne CD
    Contemp Clin Trials; 2018 Aug; 71():113-123. PubMed ID: 29787859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.